Viewing Study NCT00138658


Ignite Creation Date: 2025-12-25 @ 12:05 AM
Ignite Modification Date: 2026-02-22 @ 1:22 AM
Study NCT ID: NCT00138658
Status: COMPLETED
Last Update Posted: 2012-02-06
First Post: 2005-08-26
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study of OGX-011/Gemcitabine/Platinum-Based Regimen in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC)
Sponsor: Achieve Life Sciences
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: OGX-011-05
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators